Not Yet RecruitingN/AOther

Hemodynamic Responses to Laryngoscopy and Tracheal Intubation

Sponsored by Assiut University

NCT ID
NCT07783256
Target Enrollment
70 participants
Start Date
2026-12-20
Est. Completion
2028-12-20

About This Study

Laryngoscopy and tracheal intubation lead to tachycardia and hypertension due to increase in the plasma catecholamines subsequent to sympathetic stimulation.

Conditions Studied

Hemodynamic Response to Laryngoscopy and Tracheal Intubation

Interventions

  • ketodex
  • ketofol

Eligibility

Age:18 Years - 60 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Adult patients scheduled for elective middle ear surgery under general anesthesia, ASA status I-II, aged from 18 to 60 years old of either sex.

Exclusion Criteria:

* Full stomach or emergency surgery
* Any known contraindications or allergy to ketamine, dexmedetomidine, or propofol
* Pregnancy or breastfeeding women
* Body mass index (BMI) \> 35 Kg/m2
* History of hepatic, renal, or cardiac disease
* Patients in whom the duration of laryngoscopy will last more than 25 seconds
* Chronic opioid use, or history of neuropsychiatric disorders
* Patient refusal

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Seham M Moeen, M.D.
CONTACT
01006386324seham.moeen@aun.edu.eg
Mohammed F Aly
CONTACT
01002610390rescu2016@aun.edu.eg
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source